← back to search

Hideo Watanabe

St. Catherine University · US
Area of research
Molecular Biology · Immunology
Research interest
Research interests include interferon and immune responses, Epigenetics and DNA Methylation, Lung Cancer Research Studies, and RNA modifications and cancer.
h-index
48
citations
9,864
works
726
NIH funding
primary concept
email

Recent publications

Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer
Cancer Research Communications 2024cited by 21position: middledoi
Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression
Nature Communications 2022cited by 32position: middledoi
Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung Cancer
American Journal of Respiratory and Critical Care Medicine 2022cited by 28position: lastdoi
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Cancer Discovery 2018cited by 508position: middledoi
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
Nature Medicine 2018cited by 312position: middledoi
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS
Cancer Cell 2018cited by 72position: middledoi
Regulatory Architecture of the LβT2 Gonadotrope Cell Underlying the Response to Gonadotropin-Releasing Hormone
Frontiers in Endocrinology 2018cited by 31position: middledoi
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Cancer Discovery 2017cited by 141position: middledoi
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Nature Communications 2017cited by 120position: middledoi
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases
Experimental & Molecular Medicine 2017cited by 95position: middledoi
<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma
JAMA Oncology 2015cited by 651position: middledoi
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers
Nature Genetics 2015cited by 358position: middledoi
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
Cancer Cell 2014cited by 388position: middledoi
Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma
Molecular Cell 2013cited by 282position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tran C. Thai · Harvard University3 papers (2018–2024)David A. Barbie · Harvard University3 papers (2018–2024)Charles A. Powell · Mount Sinai Health System3 papers (2017–2022)Glenn Dranoff · Dana-Farber Cancer Institute2 papers (2014–2015)Ayushi S. Patel · RK University2 papers (2022–2022)Paul T. Kirschmeier · Center for Cancer Research2 papers (2018–2018)Abhilasha Sinha · Gene Therapy Laboratory2 papers (2022–2022)Shoichiro Tange · Sapporo Medical University2 papers (2018–2018)Ranran Kong · Second Affiliated Hospital of Xi'an Jiaotong University2 papers (2022–2022)Matthew Meyerson · Harvard University2 papers (2013–2015)Cloud P. Paweletz · Harvard University2 papers (2018–2024)Shunsuke Kitajima · Kanazawa University2 papers (2018–2018)Jun Zhu · China National Nuclear Corporation2 papers (2022–2022)Elena V. Ivanova · Brigham and Women's Hospital2 papers (2018–2024)Gordon J. Freeman · Harvard University2 papers (2014–2015)Sujuan Guo · Virginia Tech2 papers (2018–2018)Seungyeul Yoo · Sema4 (United States)2 papers (2022–2022)Dawei Yang · Central South University2 papers (2022–2022)Kwok‐Kin Wong · NYU Langone Health2 papers (2014–2018)Mary Beth Beasley · Icahn School of Medicine at Mount Sinai2 papers (2017–2022)